2018 Press Releases

    2018 | 2017 | 2016 | 2015 | 2014
    June 21, 2018
    Blueprint Medicines Initiates VOYAGER Phase 3 Clinical Trial of Avapritinib in Patients with Advanced Gastrointestinal Stromal Tumors
    June 15, 2018
    Blueprint Medicines Announces Updated Data from Ongoing Phase 1 EXPLORER Clinical Trial of Avapritinib in Patients with Advanced Systemic Mastocytosis Showing Profound and Durable Clinical Activity
    June 04, 2018
    Blueprint Medicines and CStone Pharmaceuticals Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Avapritinib, BLU-554 and BLU-667 in Greater China
    May 31, 2018
    Blueprint Medicines to Present at Upcoming Investor Conferences in June
    May 17, 2018
    Blueprint Medicines Announces Data Presentations at Upcoming ASCO and EHA Meetings Supporting Plans for Rapid Development of Avapritinib in Patients with Gastrointestinal Stromal Tumors and Systemic Mastocytosis
    May 02, 2018
    Blueprint Medicines Reports First Quarter 2018 Financial Results
    April 25, 2018
    Blueprint Medicines to Report First Quarter 2018 Financial Results on Wednesday, May 2, 2018
    April 15, 2018
    Blueprint Medicines Publication in Cancer Discovery Highlights Preclinical and Clinical Proof-of-Concept Data for Highly Selective RET Inhibitor BLU-667
    April 15, 2018
    Blueprint Medicines Announces Proof-of-Concept Data for Highly Selective RET Inhibitor BLU-667 from Phase 1 ARROW Clinical Trial in Patients with RET-Altered Solid Tumors
    March 14, 2018
    Blueprint Medicines to Present Proof-of-Concept Data from Ongoing Phase 1 Clinical Trial of BLU-667 in Patients with RET-Altered Solid Tumors in a Clinical Trials Plenary Session at AACR Annual Meeting 2018
    March 06, 2018
    Blueprint Medicines to Present at Cowen and Company 38th Annual Health Care Conference
    February 21, 2018
    Blueprint Medicines Reports Fourth Quarter and Full Year 2017 Financial Results
    February 14, 2018
    Blueprint Medicines to Report Fourth Quarter and Full Year 2017 Financial Results on Wednesday, February 21, 2018


    Print Page  | E-mail Page  | RSS Feeds  | E-mail Alerts  | Financial Tear Sheet